JanOne Inc. has added two members to its impressive scientific advisory board. John Cooke, MD, PhD will contribute his esteemed depth of vascular expertise to help guide the success of clinical therapeutic for the treatment of PAD. Alan Kaye, MD, PhD, is an internationally renowned anesthesiologist and pharmacologist whose pain management research and clinical formulation expertise will play a critical role in advancing efforts to bring non-addictive pain solutions to market. Dr. Kaye has a long, well-regarded professional background that includes serving in the United States Army Medical Reserves as a captain for seven years and five years as major. Earning his doctorate from the University of Arizona Medical School and a PhD in pharmacology from Tulane School of Medicine, Dr. Kaye also completed a pain fellowship at Texas Tech University Health Sciences Center. Today, his expertise can be attributed to over 800 publications and he is the author of over 40 books, many related to pain management. Dr. Kaye brings significant clinical pain formulation expertise, most recently assisting with the formulation of sustained release gabapentin for FDA approval.